Codes / ICD10CM / H35.359

H35.359 Cystoid macular degeneration, unspecified eye

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Cystoid Macular Degeneration, Unspecified Eye

Summary

Cystoid macular degeneration is a condition characterized by the formation of cyst-like spaces in the macula, the central part of the retina responsible for sharp central vision. This can lead to swelling (edema) and progressive vision loss, often due to fluid accumulation in the retinal layers. The condition may be associated with underlying ocular or systemic factors.

Causes

The primary cause is fluid accumulation in the macula, which can result from disrupted retinal pigment epithelium function or leakage from retinal blood vessels. It may occur secondary to conditions like diabetic retinopathy, retinal vein occlusion, or as a complication of eye surgery (e.g., cataract extraction). In some cases, it is idiopathic (without a clear underlying cause).

Risk Factors

  • Underlying ocular conditions (e.g., diabetic retinopathy, uveitis).
  • Systemic diseases (e.g., diabetes, hypertension).
  • Prior eye surgeries or procedures.
  • Use of certain medications (e.g., corticosteroids).
  • Advanced age.

Symptoms

  • Blurred or distorted central vision.
  • Reduced visual acuity.
  • Difficulty reading or recognizing fine details.
  • Metamorphopsia (distorted perception of straight lines).
  • Scotomas (blind spots) in the central visual field.

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilation to assess the retina. Optical coherence tomography (OCT) is commonly used to visualize cyst-like structures and fluid accumulation in the macula. Fluorescein angiography may be performed to identify leakage from retinal blood vessels. Visual acuity testing and other functional assessments help evaluate the extent of vision loss.

Treatment Options

Treatment focuses on addressing underlying causes and reducing macular edema. Options may include anti-VEGF injections to inhibit fluid leakage, corticosteroids (topical or injectable) to reduce inflammation, and management of associated conditions like diabetes. In some cases, laser therapy or surgical interventions may be considered.

Prognosis and Follow-Up

Prognosis varies depending on the underlying cause and severity of the condition. Early diagnosis and treatment can help preserve vision, but some degree of permanent vision loss may occur. Regular follow-up with an ophthalmologist is essential to monitor disease progression and adjust treatment as needed.

Complications

Potential complications include permanent vision loss, scarring of the macula, and progression to more severe retinal disorders. Chronic edema may lead to irreversible damage to retinal tissue.

Lifestyle & Prevention

  • Manage systemic conditions like diabetes or hypertension to reduce risk.
  • Avoid smoking, which may exacerbate retinal damage.
  • Protect eyes from injury and UV exposure.
  • Follow post-surgical care instructions if applicable.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, such as blurring, distortion, or loss of central vision. Regular eye exams are recommended for those with risk factors to detect early signs of the condition.

Tips for Medical Coders

Use H35.359 for unspecified eye involvement. Document the absence of laterality (right/left) and any associated underlying conditions. Ensure clinical documentation supports the diagnosis and specifies if the condition is idiopathic or secondary to another disorder.

Book a walkthrough

H35.359 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.